Foghorn Therapeutics FHTX
NASDAQ FHTX
$3.52 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Foghorn Therapeutics (FHTX) Short term Debt (2019 - 2020)

Updated

Foghorn Therapeutics (FHTX) recorded Short term Debt of $5.99 million in Q3 2020.

Analysis

Foghorn Therapeutics (FHTX) Short term Debt (2019 - 2020) Analysis & Trends

At the end of FY2019, Foghorn Therapeutics reported Short term Debt of $4.15 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Foghorn Therapeutics 206.67 Mn -119.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 5.99 Mn
Dec 31, 2019 4.15 Mn
API Access

Foghorn Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=FHTX&period=max&api_key=YOUR_API_KEY